KalVista Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VR ADVISER, LLC | 05/15/2026 | 6.47 M | $130.33 M | -3.78% | 12.81% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 4.96 M | $99.87 M | -1.56% | 9.82% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 4.77 M | $95.99 M | 0.00% | 9.44% |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2026 | 4.57 M | $92.07 M | 0.00% | 9.05% |
| BLACKROCK, INC. | 05/13/2026 | 3.80 M | $76.41 M | 1.11% | 7.51% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2026 | 2.88 M | $57.90 M | 18.51% | 5.69% |
| CAPITAL WORLD INVESTORS | 05/13/2026 | 2.81 M | $56.54 M | 0.00% | 5.56% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 2.14 M | $43.02 M | -6.43% | 4.23% |
| STATE STREET CORP | 05/15/2026 | 1.96 M | $39.37 M | 2.31% | 3.87% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 1.91 M | $38.49 M | -33.99% | 3.78% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 1.85 M | $37.24 M | -2.12% | 3.66% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 1.84 M | $36.95 M | 3.79% | 3.63% |
| 05/15/2026 | 1.83 M | $36.85 M | 100.00% | 3.62% | |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 1.82 M | $36.66 M | 0.55% | 3.60% |
| WOODLINE PARTNERS LP | 05/15/2026 | 1.51 M | $30.39 M | -21.40% | 2.99% |
| OCTAGON CAPITAL ADVISORS LP | 05/15/2026 | 1.45 M | $29.19 M | 13.87% | 2.87% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 1.43 M | $28.79 M | 100.00% | 2.83% |
| EMERALD ADVISERS, LLC | 05/04/2026 | 1.26 M | $25.44 M | -5.70% | 2.50% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 1.24 M | $24.88 M | 54.50% | 2.45% |
| 05/15/2026 | 1.02 M | $20.56 M | 27.46% | 2.02% | |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 1.00 M | $20.13 M | 100.00% | 1.98% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 996.24 K | $20.06 M | 5.52% | 1.97% |
| 05/15/2026 | 985.10 K | $19.83 M | 40.73% | 1.95% | |
| 05/14/2026 | 897.68 K | $18.07 M | 131.38% | 1.78% | |
| FREESTONE GROVE PARTNERS LP | 05/15/2026 | 882.91 K | $17.77 M | 39.48% | 1.75% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 824.29 K | $16.59 M | -1.32% | 1.63% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 05/04/2026 | 805.76 K | $16.22 M | -5.81% | 1.59% |
| GREAT POINT PARTNERS LLC | 05/15/2026 | 675.00 K | $13.59 M | -1.55% | 1.34% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 584.35 K | $11.76 M | -15.94% | 1.16% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2026 | 564.04 K | $11.35 M | 100.00% | 1.12% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 555.63 K | $11.18 M | 42.54% | 1.10% |
| BARCLAYS PLC | 05/15/2026 | 537.06 K | $10.81 M | -23.34% | 1.06% |
| UBS GROUP AG | 05/05/2026 | 515.65 K | $10.38 M | 38.62% | 1.02% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 05/14/2026 | 506.74 K | $9.30 M | -56.75% | 1.00% |
| MORGAN STANLEY | 05/15/2026 | 439.10 K | $8.84 M | -37.29% | 0.87% |
| CATALIO CAPITAL MANAGEMENT, LP | 05/15/2026 | 426.55 K | $8.59 M | 100.00% | 0.84% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 05/13/2026 | 376.00 K | $7.57 M | 10.00% | 0.74% |
| NORTHERN TRUST CORP | 05/14/2026 | 363.69 K | $7.32 M | 3.33% | 0.72% |
| 05/08/2026 | 362.90 K | $7.31 M | 100.00% | 0.72% | |
| 05/07/2026 | 351.31 K | $7.07 M | 100.00% | 0.70% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 323.45 K | $6.51 M | -0.28% | 0.64% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 315.54 K | $6.35 M | 3.16% | 0.62% |
| HRT FINANCIAL LP | 05/14/2026 | 286.92 K | $5.78 M | -0.05% | 0.57% |
| JEFFERIES FINANCIAL GROUP INC. | 05/08/2026 | 286.05 K | $5.76 M | 100.00% | 0.57% |
| 05/15/2026 | 276.75 K | $5.57 M | 100.00% | 0.55% | |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 276.39 K | $5.56 M | 100.00% | 0.55% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2026 | 267.40 K | $5.38 M | -25.06% | 0.53% |
| ATOM INVESTORS LP | 05/15/2026 | 245.99 K | $4.95 M | -10.91% | 0.49% |
| CITIGROUP INC | 05/11/2026 | 244.26 K | $4.92 M | 2,167.77% | 0.48% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 229.98 K | $4.63 M | 558.43% | 0.46% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
KalVista Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 214 institutional investors and hedge funds held shares of KalVista Pharmaceuticals Inc. The most heavily invested institutionals were:
VR Adviser, LLC: 6.47 M
Frazier Life Sciences Management, L.P.: 4.96 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 4.77 M
TANG CAPITAL MANAGEMENT LLC: 4.57 M
BlackRock, Inc.: 3.8 M
SILVERARC CAPITAL MANAGEMENT, LLC: 2.88 M
137.03% of KalVista Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 73.60 M shares in the last 24 months. This purchase volume represents approximately $1.27 B in transactions.